Skip to content

US · IVF · MEDICAL - DEVICES

INVO Fertility, Inc. (IVF) intrinsic value and stock valuation

$1.76as of 2026-11-21 · Mkt cap 1.92M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

INVO Fertility, Inc. DCF and intrinsic value

InvestorsCraft values IVF with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from IVF’s statements →

INVO Fertility, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices Sarasota, FL 34240 invofertility.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$6.84M+45.7% 5y CAGRd
20112025
Net income
-$-23.32M
20112025
Free cash flow
-$-7.06M
20112025
Total equity
$7.22M+4.7% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$6.84M$6.53M$3.02M$820K$4.16M
Operating income-$-5.84M-$-8.13M-$-6.77M-$-10.63M-$-5.22M
Net income-$-23.32M-$-9.1M-$-8.03M-$-10.89M-$-6.65M
EPSd-$-194.33M-$-227.5M-$-401.5M-$-1.09B-$-665M
Operating cash flow-$-7.01M-$-2.97M-$-4.76M-$-6.6M-$-6.03M
Capital expenditure-$-40K-$-180K-$-440K-$-10K-$-450K
Free cash flow-$-7.06M-$-3.16M-$-5.2M-$-6.62M-$-6.48M
Total assets$20.2M$46.5M$18.5M$3.71M$10.5M
Total debt$3.4M$9.9M$6.3M$2.27M$2.12M
Net debt$1.32M$9.15M$6.07M$2.18M-$-3.56M
Total equity$7.22M$12.8M$890K-$-980K$7.31M
Cash and short-term investments$2.08M$740K$230K$90K$5.68M
Income statement
20252024202320222021
Revenue$6.84M$6.53M$3.02M$820K$4.16M
Cost of revenue$4.31M$3.66M$1.93M$850K$150K
Gross profit$2.53M$2.87M$1.09M-$-30K$4.02M
Research and development expenses$0.00$490K$170K$540K$220K
Selling, general and administrative expenses$7.69M$9.08M$7.49M$9.98M$9.02M
Other expenses$680K$1.43M$200K$80K$0.00
Operating expenses$8.37M$11M$7.65M$10.6M$9.23M
Cost and expenses$12.7M$14.7M$9.79M$11.5M$9.38M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$1.3M$1.06M$930K$60K$1.27M
Depreciation and amortization$680K$920K$200K$80K$170K
Ebitda-$-3.51M-$-7.14M-$-6.88M-$-10.75M-$-5.22M
Operating income-$-5.84M-$-8.13M-$-6.77M-$-10.63M-$-5.22M
Total other income/expenses, net$350K-$-990K-$-1.24M-$-260K-$-1.43M
Income before tax-$-5.49M-$-9.12M-$-8.01M-$-10.89M-$-6.65M
Income tax expense-$-150K-$-20K$30K$0.00$0.00
Net income-$-23.32M-$-9.1M-$-8.03M-$-10.89M-$-6.65M
Weighted average shares outstanding$120K$40K$20K$10K$10K
Weighted average diluted shares outstanding$120K$40K$20K$10K$10K
Balance sheet
20252024202320222021
Cash and short-term investments$2.08M$740K$230K$90K$5.68M
Net receivables$220K$170K$140K$80K$50K
Inventory$230K$220K$260K$260K$290K
Total current assets$2.76M$1.32M$1.26M$620K$6.31M
Property, plant and equipment, net$1.67M$2.75M$4.19M$1.85M$2.54M
Goodwill and intangible assets$7.2M$41.6M$9.97M$0.00$130K
Long-term investments$2.47M$740K$3.09M$1.24M$1.49M
Total non-current assets$17.5M$45.1M$17.3M$3.09M$4.16M
Total assets$20.2M$46.5M$18.5M$3.71M$10.5M
Accounts payable$2.03M$5.71M$2.33M$1.35M$440K
Short-term debt$1.48M$6.58M$1.69M$920K$220K
Deferred revenue$720K$600K$410K$120K$10K
Total current liabilities$10.3M$17.9M$8M$3.34M$1.25M
Long-term debt$1.92M$3.32M$4.61M$1.35M$1.9M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$2.66M$15.8M$9.61M$1.35M$1.9M
Capital lease obligations$1.38M$2.43M$3.54M$1.51M$2.12M
Total liabilities$13M$33.7M$17.6M$4.69M$3.16M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-91.37M-$-67.16M-$-57.82M-$-49.78M-$-38.89M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$7.22M$12.8M$890K-$-980K$7.31M
Total investments$2.47M$740K$3.09M$1.24M$1.49M
Total debt$3.4M$9.9M$6.3M$2.27M$2.12M
Net debt$1.32M$9.15M$6.07M$2.18M-$-3.56M
Cash flow statement
20252024202320222021
Net income-$-23.32M-$-9.1M-$-8.03M-$-10.89M-$-6.65M
Depreciation and amortization$680K$920K$200K$80K$170K
Stock-based compensation$1.47M$1.59M$1.39M$2.22M$2.71M
Change in working capital-$-1.68M$1.86M$470K$1.48M-$-3.61M
Accounts receivable-$-100K-$-30K-$-60K-$-30K-$-30K
Inventory-$-10K$40K-$0.00$20K-$-20K
Accounts payable-$-1.32M$1.35M$920K$900K$110K
Net cash provided by operating activities-$-7.01M-$-2.97M-$-4.76M-$-6.6M-$-6.03M
Investments in property, plant and equipment-$-40K-$-180K-$-440K-$-10K-$-420K
Acquisitions, net-$-2.7M$470K-$-2.05M-$-70K-$-1.7M
Net cash used for investing activities-$-2.75M$360K-$-2.49M-$-80K-$-2.15M
Common stock issued$13.5M$170K$5.7M$290K$3.65M
Common stock repurchased-$-4M$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$11.1M$3.12M$7.39M$1.09M$3.77M
Net change in cash$1.34M$510K$140K-$-5.59M-$-4.41M
Cash at end of period$2.08M$740K$230K$90K$5.68M
Operating cash flow-$-7.01M-$-2.97M-$-4.76M-$-6.6M-$-6.03M
Capital expenditure-$-40K-$-180K-$-440K-$-10K-$-450K
Free cash flow-$-7.06M-$-3.16M-$-5.2M-$-6.62M-$-6.48M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About INVO Fertility, Inc.

        INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

        CEO
        Steven Shum
        Employees
        42
        Beta
        2.32

        Explore

        Frequently asked questions

        What is the intrinsic value of INVO Fertility, Inc. (IVF)?

        InvestorsCraft does not currently publish an intrinsic value for IVF. How the IC value is calculated.

        Is IVF undervalued?

        InvestorsCraft does not publish an undervaluation signal for IVF at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.